The two programs will be offered to students and CVS interns.
CVS Health provides tuition assistance and scholarships for students enrolled in pharmacy schools. In a press release,1 the organization announced that it is adding two new offerings.
The first is a tuition assistance program for CVS Pharmacy interns called the PharmD program. All interns at the pharmacy are eligible to apply and can receive up to $20,000 per year. According to the release, 21 students will be selected. The program will start with the summer of 2024, and in fall 2024, it will expand for students in their final two years of pharmacy education.
In the press release, executive vice president and chief pharmacy officer at CVS Prem Shah said, “As leaders in community pharmacy, we are committed to investing in the future of pharmacy, particularly to support the next generation of students with financial assistance and hands-on experience necessary to further their careers. We recognize the strong, enduring bond between pharmacists and the communities they serve. CVS Pharmacy will continue to advance the practice of pharmacy and provide more opportunities for students to enter this important area of health care."
Shah is also president of pharmacy and consumer wellness at CVS. He also discussed the other new program, the CVS Health/AACP Student Advocacy & Community Health Equity Award. He said, “Providing culturally competent care is critical to meeting the needs of the many different communities we serve. Our goal is to recruit candidates who are advocates for health equity and the well-being of their patients."
The award is intended to promote diversity of thought, background, perspective, and experience, and students hoping to receive it will need to demonstrate leadership, academic success, financial need and a commitment to advancing the profession of pharmacy care.
"AACP is committed to fostering a diverse pharmacy workforce that will advance the profession and improve patient care," said Lee Vermeulen, BSPharm, MS, FCCP, FFIP, Executive Vice President and CEO of AACP. "We are grateful for our partnership with CVS Health and for their help in meeting the financial needs of students who will provide quality care to patients in communities that are too often underserved and suffer health disparities."
Fake Weight Loss Drugs: Growing Threat to Consumer Health
October 25th 2024In this episode of the Pharmaceutical Executive podcast, UpScriptHealth's Peter Ax, Founder and CEO, and George Jones, Chief Operations Officer, discuss the issue of counterfeit weight loss drugs, the potential health risks associated with them, increasing access to legitimate weight loss medications and more.
MDMA Therapy for Mental Health Conditions: Do the Benefits Outweigh the Risks?
October 25th 2024Despite a recent FDA Complete Response Letter issued to Lykos for midomafetamine capsules for the treatment of post-traumatic stress disorder, experts believe that the future is bright for psychedelic drugs that treat mental health conditions.
The Transformative Role of Medical Information in Customer Engagement
October 3rd 2024Stacey Fung, Head of Global Medical Information at Gilead Lifesciences, delves into the evolving role of Medical Information (MI) in the pharmaceutical industry. Covering key topics like patient engagement through omnichannel strategies, combating misinformation, and leveraging AI to enhance medical inquiries, the conversation with Stacey highlights MI's critical role in ensuring patient safety and supporting drug development. She also shares her professional journey and tidbits for early career professionals on professional development.
The Impact of Artificial Intelligence on the Creation of Medicines
October 24th 2024Najat Khan, chief R&D officer, chief commercial officer, Recursion, and Fred Hassan, director, Warburg Pincus, discuss how artificial intelligence can help reduce healthcare costs at the 20th Annual Young & Partners Pharmaceutical Executive Summit held at the Yale Club of New York.